Cargando…
Ocular Drug Delivery to the Retina: Current Innovations and Future Perspectives
Treatment options for retinal diseases, such as neovascular age-related macular degeneration, diabetic retinopathy, and retinal vascular disorders, have markedly expanded following the development of anti-vascular endothelial growth factor intravitreal injection methods. However, because intravitrea...
Autores principales: | Kim, Hyeong Min, Woo, Se Joon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830424/ https://www.ncbi.nlm.nih.gov/pubmed/33467779 http://dx.doi.org/10.3390/pharmaceutics13010108 |
Ejemplares similares
-
Ocular Drug Delivery: Advancements and Innovations
por: Tian, Bo, et al.
Publicado: (2022) -
Innovative Strategies for Drug Delivery to the Ocular Posterior Segment
por: Gabai, Andrea, et al.
Publicado: (2023) -
Nonionic Surfactant Vesicles in Ocular Delivery: Innovative Approaches and Perspectives
por: Sahoo, Ranjan Ku., et al.
Publicado: (2014) -
Current State and Future Perspectives on Gastroretentive Drug Delivery Systems
por: Tripathi, Julu, et al.
Publicado: (2019) -
Nanomedicine and drug delivery to the retina: current status and implications for gene therapy
por: Tawfik, Mohamed, et al.
Publicado: (2022)